JPMorgan downgraded Fabrinet to Neutral from Overweight with a price target of $210, up from $185. In conjunction with its 2024 hardware and networking outlook report, the firm made several rating changes. Fabrinet’s arterial intelligence driven premium valuation leaves limited room for upside on shares price despite its opportunities for upside on sell-side consensus estimates, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on FN: